Navigation Links
Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C

red at doses as low as one twentieth of the recommended human dose of REBETOL. If pregnancy occurs in a patient or partner of a patient during treatment or during the 6 months after treatment stops, physicians are encouraged to report such cases by calling (800) 727-7064.

There are no new adverse events specific to PEGINTRON as compared to INTRON(R) A (Interferon alfa-2b, recombinant) for Injection; however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. The most common adverse events associated with PEGINTRON were "flu- like" symptoms, occurring in approximately 50 percent of patients, which may decrease in severity as treatment continues. Application site disorders were common (47 percent), but all were mild (44 percent) or moderate (4 percent) and no patient discontinued, and included injection site inflammation and reaction (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2 percent of patients receiving PEGINTRON. Alopecia (thinning of the hair) is also often associated with alpha interferons including PEGINTRON.

Psychiatric adverse events, which include insomnia, were common (57 percent) with PEGINTRON but similar to INTRON A (58 percent). Depression was most common at 29 percent. Suicidal behavior including ideation, suicidal attempts, and completed suicides occurred in 1 percent of patients during or shortly after completing treatment with PEGINTRON.

PEGINTRON/REBETOL is contraindicated in patients with autoimmune hepatitis, decompensated liver disease, and in patients with hemoglobinopathies (e.g., thalassemia major, sickle-cell anemia).

The following serious or clinically significant adverse events have been reported at a frequency less than 1 percent with PEGINTRON or interferon alpha: severe decreases in neutrophil or platelet counts, hypothyroidism, hyperglycemia, hypotension, arrhythmia, ulcerative and hemorrhagic colitis, development or exacerbation of aut
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
2. Schering-Plough Announces Presentation of Phase II Trial Results for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual Meeting of The American College of Cardiology/i2 Summit
3. New Position Statement from The North American Menopause Society Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women
4. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
5. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
6. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
7. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
8. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
9. Major Manufacturer of Unapproved and Adulterated Drugs
10. Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data
11. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
Post Your Comments:
(Date:10/1/2014)...   Plexus Information Systems, Inc. (Plexus ... Systems (AIMS), announced a partnership with NextGen ... subsidiary of Quality Systems, Inc. and a leading ... Logo - http://photos.prnewswire.com/prnh/20140930/149406 ... This partnership extends the NextGen Healthcare product portfolio ...
(Date:10/1/2014)... NOTTINGHAM, England , Oct. 1, 2014  Columbia ... that its subsidiary, Molecular Profiles Ltd., is set to ... annual CPhI/ICSE Worldwide event in Paris ... the rapid development of both standard and complex drug ... which incorporates the company,s existing formulation and analytical development ...
(Date:10/1/2014)... and NEW YORK , October 1, ... Research Organization (CRO) and service provider for the medical industries, announced ... of offices in New York City . genae ... City is strategically centered in one of the highest ... Coast", said Philippe Kassab , President at genae Americas. "The ...
Breaking Medicine Technology:Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 2Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 3Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 2Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 3genae Opens Offices in New York City 2
... a Deadly ... but Vaccine-Preventable Disease, WASHINGTON, Oct. 16 Parents ... its national,educational campaign "Silence the Sounds of Pertussis" with actress ... about the dangers of pertussis and alerts,parents to the need ...
... West Pharmaceutical,Services, Inc. (NYSE: WST ) today ... Thomas W. Hofmann. Mr. Hofmann, 56, is Senior Vice,President ... SUN ), a,position he has held since 1998. He ... largest independent,refiner-marketers of petroleum products in the United States. ...
Cached Medicine Technology:Actress and New Mom Keri Russell Joins PKIDs to launch 'Silence the Sounds of Pertussis' Campaign 2Actress and New Mom Keri Russell Joins PKIDs to launch 'Silence the Sounds of Pertussis' Campaign 3West Pharmaceutical Services, Inc. Appoints New Director 2
(Date:10/1/2014)... Phoseon Technology, the pioneer in developing ... the business worldwide. This rapid growth includes increased hiring ... manufacturing efforts. The company has experienced average annual growth ... expects this growth to continue in the future as ... adoption. , “We are very pleased that ...
(Date:10/1/2014)... 01, 2014 Farmington Company today ... redefined mission and visual identity helping brokers, consultants ... with them to create greater benefit communication synergies. ... focuses on empowering customers to better leverage Farmington ... crown jewel of the rebrand is the refreshed ...
(Date:10/1/2014)... N.C. A new genetic finding from Duke Medicine ... anxiety and depression might also be hard-wired to gain ... and heart disease. , An estimated 13 percent of ... genetic susceptibility, and knowing this could help them reduce ... diet, exercise and stress management. , "Genetic susceptibility, psychosocial ...
(Date:10/1/2014)... October 01, 2014 Between 23 million ... the U.S., according to figures from the National Institutes ... Association (AARDA), and many of them have something else ... having undiagnosed celiac disease. Gluten Free Therapeutics, makers ... of undiagnosed celiac disease by publishing a series of ...
(Date:10/1/2014)... Jersey City, NJ (PRWEB) October 01, 2014 ... sticking with their intentions to lose weight and their dieting ... in unhealthy, fatty foods. Including hormone diet treatments ... not only allows patients to see fast and effective weight ... diet and begin forming healthy habits to maintain their weight ...
Breaking Medicine News(10 mins):Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4
... ... Saudi Arabia, SOMERSET, N.J., ... subsidiary AWT International, Inc.,has opened new sales offices in Saudi Arabia. ... U.S. healthcare industry. The Company has hired 2 highly experienced ...
... one source of frustration, study finds , TUESDAY, Oct. 9 ... U.S. Hispanics, ability to get good health care, a new ... have difficulty navigating the health care system, say researchers reporting ... , In this study, a team led by Robert Weech-Maldonado, ...
... Oct. 8, 2007 Two UT Southwestern Medical Center ... neuroscientist have been elected to the Institute of ... Sciences. , Dr. Luis Parada, professor and chairman ... chairman of neuroscience, were among 65 new national members ...
... financial and clinical ... -- Announces name change from ... Today, UPCARE Technology, Inc.,unveiled its new UPCARE(R) E2E lab performance ... of its parent company, Marquette,General Health System (MGHS). The company ...
... Oct. 9 Many Americans are obsessed with,staying in ... being,mentally fit. More Americans are becoming aware of the ... knowledge, intelligence, and quick,wits are rewarded. Being mentally fit ... train your brain have been lacking,until recently. A ...
... Award-winning Internet job board establishes new social and professional ... and health care community, LAKE WORTH, Fla., Oct. 9 ... care field, your job is extremely demanding, perhaps,even all-consuming. Finding ... tough, as is catching up on the latest industry news ...
Cached Medicine News:Health News:AWT, Inc. Continues Rapid Expansion in Middle East 2Health News:AWT, Inc. Continues Rapid Expansion in Middle East 3Health News:Many U.S. Hispanics Struggle With Health Care System 2Health News:2 UT Southwestern researchers elected to National Academy of Sciences' Institute of Medicine 2Health News:2 UT Southwestern researchers elected to National Academy of Sciences' Institute of Medicine 3Health News:UPCARE Technology to Share the Secrets of its Parent's Success in Lab Outreach 2Health News:UPCARE Technology to Share the Secrets of its Parent's Success in Lab Outreach 3Health News:UPCARE Technology to Share the Secrets of its Parent's Success in Lab Outreach 4Health News:Online Game from BrainGrade Can Raise Brain I.Q. 2Health News:Absolutely Health Care Launches MedicalMingle.com 2
... level. Incredibly quiet, yet very powerful. Attachment ... at one time eliminates the need to ... canister set-up is for Abbott 2000ml system ... and CE marks. Includes a wireless foot-switch. ...
Richardson Retractors...
Our most popular saline breast implant style for over 20 years. A full, rounded look that adds greater dimension to the breast....
Inquire...
Medicine Products: